» Articles » PMID: 28870248

Functional and Quality of Life Outcomes After Partial Glossectomy: a Multi-institutional Longitudinal Study of the Head and Neck Research Network

Abstract

Background: While aggressive treatment for oral cancer may optimize survival, decrements in speech and swallowing function and quality of life often result. This exploratory study investigated how patients recover their communicative function, swallowing ability, and quality of life after primary surgery [with or without adjuvant (chemo)radiation therapy] for tongue cancer over the course of the first year post-operation.

Methods: Patients treated for oral cancer at three institutions (University of Alberta Hospital, Mount Sinai Beth Israel Medical Center, and Turku University Hospital) were administered patient-reported outcomes assessing speech [Speech Handicap Index (SHI)], swallowing [(M.D. Anderson Dysphagia Inventory (MDADI)] and quality of life [European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Head and Neck Module (EORTC-H&N35)]. Outcome measures were completed pre-operatively and at 1-, 6-, and 12-months post-operatively.

Results: One hundred and seventeen patients undergoing partial glossectomy with reconstruction participated in this study. Results indicated no significant differences in swallowing function (MDADI and EORTC-H&N35 subscales) between baseline and 6 months post-surgery and no significant differences in speech function (SHI subscales) between baseline and 1 year post-surgery. Most quality of life domains (EORTC-H&N35 subscales) returned to baseline levels by 1 year post-operation, while difficulties with dry mouth and sticky saliva persisted. A clear time trend of adjuvant (chemo)radiation therapy negatively affecting dry mouth scores over time was identified in this study, while negative independent effects of chemoradiation on MDADI swallowing, and EORTC-H&N35 swallowing, eating, and opening mouth subscales were found.

Conclusions: Assessment time influenced patient-reported speech, swallowing, and quality of life outcomes, while treatment (by time) effects were found for only swallowing and quality of life outcomes. Results of the present study will help guide clinical care and will be useful for patient counseling on expected short and long-term functional and quality of life outcomes of surgical and adjuvant treatment for oral cavity cancer.

Citing Articles

Epidemiology, Diagnostics, and Therapy of Oral Cancer-Update Review.

Kijowska J, Grzegorczyk J, Gliwa K, Jedras A, Sitarz M Cancers (Basel). 2024; 16(18).

PMID: 39335128 PMC: 11430737. DOI: 10.3390/cancers16183156.


Optimising Patient Outcomes in Tongue Cancer: A Multidisciplinary Approach.

de Boer J, Barnett R, Cardin A, Cimoli M, Davies L, Delany C Cancers (Basel). 2024; 16(7).

PMID: 38610956 PMC: 11010906. DOI: 10.3390/cancers16071277.


Head and neck cancer treatment outcome priorities: A multi-perspective concept mapping study.

Alolayan W, Rieger J, Yoon M PLoS One. 2023; 18(11):e0294712.

PMID: 38033014 PMC: 10688684. DOI: 10.1371/journal.pone.0294712.


Neoadjuvant use of oncolytic herpes virus G47Δ prevents local recurrence after insufficient resection in tongue cancer models.

Inoue K, Ito H, Iwai M, Tanaka M, Mori Y, Todo T Mol Ther Oncolytics. 2023; 30:72-85.

PMID: 37583387 PMC: 10423690. DOI: 10.1016/j.omto.2023.07.002.


The Influence of the Oral Microbiome on Oral Cancer: A Literature Review and a New Approach.

Smedra A, Berent J Biomolecules. 2023; 13(5).

PMID: 37238685 PMC: 10216794. DOI: 10.3390/biom13050815.


References
1.
Panchal J, Potterton A, Scanlon E, McLean N . An objective assessment of speech and swallowing following free flap reconstruction for oral cavity cancers. Br J Plast Surg. 1996; 49(6):363-9. DOI: 10.1016/s0007-1226(96)90004-1. View

2.
Dwivedi R, Chisholm E, Khan A, Harris N, Bhide S, St Rose S . An exploratory study of the influence of clinico-demographic variables on swallowing and swallowing-related quality of life in a cohort of oral and oropharyngeal cancer patients treated with primary surgery. Eur Arch Otorhinolaryngol. 2011; 269(4):1233-9. DOI: 10.1007/s00405-011-1756-y. View

3.
Rinkel R, Verdonck-de Leeuw I, de Bree R, Aaronson N, Leemans C . Validity of patient-reported swallowing and speech outcomes in relation to objectively measured oral function among patients treated for oral or oropharyngeal cancer. Dysphagia. 2015; 30(2):196-204. DOI: 10.1007/s00455-014-9595-9. View

4.
Campbell B, Marbella A, Layde P . Quality of life and recurrence concern in survivors of head and neck cancer. Laryngoscope. 2000; 110(6):895-906. DOI: 10.1097/00005537-200006000-00003. View

5.
Borggreven P, Aaronson N, Verdonck-de Leeuw I, Muller M, Heiligers M, de Bree R . Quality of life after surgical treatment for oral and oropharyngeal cancer: a prospective longitudinal assessment of patients reconstructed by a microvascular flap. Oral Oncol. 2007; 43(10):1034-42. DOI: 10.1016/j.oraloncology.2006.11.017. View